Psychometric validation of a patient-reported measure of physical functioning in sporadic inclusion body myositis

Muscle and Nerve

Volumn 54, Issue 4, 2016, Pages 658-665

  Williams, Valerie ^a   Coles, Theresa ^a   Gnanasakthy, Ari ^a   Demuro, Carla ^a   Yarr, Stuart ^a   Williams, Nicole ^a   Lowes, Linda ^b   Alfano, Lindsay ^b   Tseng, Brian ^c  

^a RTI HEALTH SOLUTIONS   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

patient reported outcomes; physical functioning; psychometric evaluation; sporadic inclusion body myositis; validation

Indexed keywords

ADULT; AGED; ARTICLE; CONSTRUCT VALIDITY; FEMALE; FUNCTIONAL STATUS; FUNCTIONAL STATUS ASSESSMENT; HUMAN; INCLUSION BODY MYOSITIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PSYCHOMETRY; SELF REPORT; SIX MINUTE WALK TEST; VALIDATION STUDY; VERY ELDERLY; WALKING; WHEELCHAIR;

EID: 84986596702     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.25080     Document Type: Article

References (22)

1. Amato AA, Barohn RJ. Inclusion body myositis: old and new concepts. J Neurol Neurosurg Psychiatry 2009;80:1186–1193.
2. Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705–713.
3. The Myositis Association. Inclusion-Body Myositis. 2015. Available at: http://www.myositis.org/learn-about-myositis/types-of-myositis/inclusion-body-myositis. Accessed February 9, 2015.
4. Dobloug GC, Antal EA, Sveberg L, Garen T, Bitter H, Stjarne J, et al. High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study. Eur J Neurol 2015;22:672–e41.
5. Meyer A, Meyer N, Schaeffer M, Gottenberg J-E, Geny B, Sibilia J. Incidence and prevalence of inflammatory myopathies: a systematic review. Rheumatology 2015;54:50–63.
6. Catalan M, Selva-O'Callaghan A, Grau JM. Diagnosis and classification of sporadic inclusion body myositis (sIBM). Autoimmun Rev 2014;13:363–366.
7. Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N, et al. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis. Arthritis Care Res (Hoboken) 2011;63:S118–S157.
8. Jackson CE, Barohn RJ, Gronseth G, Pandya S, Herbelin L, Muscle Study Group. Inclusion body myositis functional rating scale: a reliable and valid measure of disease severity. Muscle Nerve 2008;37:473–476.
9. The ALS CNTF treatment study (ACTS) phase I-II Study Group. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group. Arch Neurol 1996;53:141–147.
10. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999;169:13–21.
11. FDA. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims. Washington, DC: Food and Drug Administration; 2009.
12. DeMuro C, Lewis S, Lowes L, Alfano L, Tseng B, Gnanasakthy A. Development of the sporadic inclusion body myositis physical functioning assessment (sIFA). Muscle Nerve (to be published).
13. Badrising UA, Maat-Schieman M, van Duinen SG, Breedveld F, van Doorn P, van Engelen B, et al. Epidemiology of inclusion body myositis in the Netherlands: a nationwide study. Neurology 2000;55:1385–1387.
14. Hilton-Jones D, Miller A, Parton M, Holton J, Sewry C, Hanna M. Inclusion body myositis: MRC centre for neuromuscular diseases, IBM workshop, London, 13 June 2008. Neuromuscular Disord 2010;20:142–147.
15. Bruce B, Fries J. The health assessment questionnaire (HAQ). Clin Exp Rheumatol 2005;23:S14.
16. Stanford University School of Medicine. The Health Assessment Questionnaire (HAQ) and the Improved HAQ. June 2009, 2014. Available at: http://aramis.stanford.edu/HAQ.html. Accessed March 29, 2012.
17. Barghout V, DeMuro C, Price M, Lewis S, Tseng B. Skeletal muscle activity and resource tool for sporadic inclusion body myositis: characterization of resource utilization and financial burden experienced by sIBM patients. Presented at the Poster presented at the 20th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Philadelphia, Pennsylvania, May 16–20, 2015.
18. Bennell K, Dobson F, Hinman R. Measures of physical performance assessments: Self-Paced Walk Test (SPWT), Stair Climb Test (SCT), Six-Minute Walk Test (6MWT), Chair Stand Test (CST), Timed Up & Go (TUG), Sock Test, Lift and Carry Test (LCT), and Car Task. Arthritis Care Res (Hoboken) 2011;63:S350–S370.
19. SAS Institute Inc. SAS proprietary software. 9.3 ed. Cary, NC: SAS Institute, Inc; 2010.
20. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297–334.
21. Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. New York: McGraw-Hill; 1994.
22. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: L. Erlbaum Associates; 1988.